Personalised reimbursement: a risk-sharing model for biomarker-driven treatment of rare subgroups of cancer patients
- PMID: 31038154
- DOI: 10.1093/annonc/mdz119
Personalised reimbursement: a risk-sharing model for biomarker-driven treatment of rare subgroups of cancer patients
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
